Delgado F, Oteros R, Jimenez-Gomez E, Bravo Rey I, Bautista MD, Valverde Moyano R. Half bolus dose of intravenous abciximab is safe and effectiveinthesettingofacutestrokeendovasculartreatment.JNeurointerv 204. Heck DV, Brown MD. Carotid stenting and intracranial thrombectomy for treatment of acute stroke due to tandem occlusions with aggres- sive antiplatelet therapy may be associated with a high incidence of intracranial hemorrhage. J Neurointerv Surg. 2015;7:170 175. doi: 205. Ernst M, Butscheid F, Fiehler J, Wittkugel O, Alfke K, Jansen O, Petersen D, Koch C, Eckert B. Glycoprotein IIb/IIIa inhibitor bridg- ing and subsequent endovascular therapy in vertebrobasilar occlu- sion in 120 patients. Clin Neuroradiol. 2016;26:169 175. doi: 206. Dippel DW, Majoie CB, RoosYB, van der Lugt A, van Oostenbrugge RJ, vanZwamWH,LingsmaHF,KoudstaalPJ,TreurnietKM,vandenBergLA, et al; for the MR CLEAN Investigators. Influence of device choice on the Powers et al 2019 Guidelines for Management of AIS e409 effect of intra-arterial treatment for acute ischemic stroke in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). Stroke. 2016;47:2574 2581. 207. The International Stroke Trial (IST): a randomised trial of aspirin, subcu- taneous heparin, both, or neither among 19435 patients with acute isch- aemic stroke: International Stroke Trial Collaborative Group. Lancet. 1997;349:1569 1581. 208. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: ran- domised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349:1641 1649. 209. Sandercock PA, Counsell C, Tseng MC, Cecconi E. Oral antiplate- let therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 210. Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H, Meng X, Cui L, et al; CHANCE Investigators. Clopidogrel with as- pirin in acute minor stroke or transient ischemic attack. N Engl J Med. 211. 